Polymorphisms influencing the binding affinity between the Fc␥ receptors and
Introduction
Fc␥ receptors are important in defence against infectious agents. Different response reactions can be initiated by binding the constant part of IgG. Various types of Fc␥ receptors exhibit different affinities toward IgG isoforms. Polymorphisms in the receptors lead to changed affinities for IgG (for review see Rascu et al 1 ) . Recent studies indicate that such receptor polymorphisms may have an impact on the susceptibiliy to infective diseases as well as the development of autoimmune diseases. The cellspecific expression patterns of these receptors differ, Fc␥RIIa is widely distributed and present on most blood cells, whereas Fc␥RIII is present on monocytes and natural killer cells, and Fc␥RIIIb is only found on neutrophils. 1 Fc␥RIIa carries a functionally important point mutation, encoding an exchange of arginine for histidine at position 131 in the amino acid sequence. Fc␥RIIa H131 reacts more effectively with IgG 1, 2 and 3 and is the only Fc␥ receptor which effectively interacts with IgG2. 2 The polymorphisms of Fc␥RIIIa and Fc␥RIIIb influence mainly the binding of IgG1 and IgG3. The affected site in Fc␥RIIIa is at position 158 with an exchange of phenylalanine for valine; that of Fc␥RIIIb is at positions 65 and 82, with glycosylation sites being influenced (see Rascu et al 1 widespread human disease leading to irreversible attachment loss, bone destruction and eventually to tooth loss. In industrialized countries periodontitis affects the majority of adults, 5-15% with severe periodontal disease. Some people are more severely affected by the sequelae of microbial infection than others. 3 Both environmental and genetic factors contribute to individual variations in the etiology of periodontal diseases. 4 Inherited factors have been proposed to explain this inter-individual variability, derived from twin studies and the elucidation of genetic polymorphisms. [5] [6] [7] The present study was designed to determine whether there is any relationship between the genotype distribution of polymorphic Fc␥ receptors and periodontal parameters in a cross-sectional protocol. To achieve this goal, adult subjects exhibiting all stages of periodontal diseases were examined clinically and radiographically to monitor the extent and severity of the periodontial disease. The genotype distribution among the patients was assessed by determination of the polymorphisms of Fc␥RIIa, Fc␥RIIIa, and Fc␥RIIIb.
and references cited herein). Periodontitis, considered a bacterial infection, is a very

Results
A total of 154 subjects (82 female and 72 male, 112 nonsmokers and 42 smokers, aged 35-75), exhibiting all stages of periodontal disease were genotyped for the Fc␥RIIa, Fc␥RIIIa, and Fc␥RIIIb polymorphisms. The genotype distributions of all subjects irrespective of their periodontal state are shown in Table 1 . The genotype frequencies are in Hardy-Weinberg equilibrium and correspond to those published in representative epidemiological studies of the normal Caucasian population. Fc␥RIIa genotypes were equally distributed independently of the severity of periodontal disease. In contrast, Fc␥RIIIa genotypes showed a difference in distribution comparing severity of bone loss. In assessing mean bone loss, an over-representation of the V allele of Fc␥RIIIa was found among individuals with a more severe form of the disease. A sub-analysis was performed assessing cases between 40 and 60 years of age excluding cases with juvenile periodontitis as well as cases where age alone is a risk factor in the development of periodontitis. The results show an over-representation of the Fc␥RIIIa-V/V genotype (P = 0.018) in cases with severe periodontitis ( Table 2) .
The Fc␥RIIIb genotype distribution showed a tendency towards an over-representation of the Fc␥RIIIb-NA2/NA2 genotype among individuals with severe bone loss ( Table 2) . Severity and extent are two different aspects of the disease. In this study, the percentage of sites exceeding a predetermined level of bone loss (Ͼ0.2, see Figure 1 ) defines the extent of the disease. In Figure 2 the measured values of bone loss are depicted, separated for each genotype of Fc␥RIIIa. The bone loss either assessed as severity or as extent, is highest among the Fc␥RIIIa-V/V homozy- gotes, medium in F/V heterozygotes, and lowest in F/F homozygotes ( Figure 2 ). Even if more stringent limits to distinguish between severe forms of the disease and minor forms are applied, these relationships are still significant for the Fc␥RIIIa polymorphism. Thus, including only subjects with more than 10% of all measured sites having a bone loss Ͼ0.3 as 'cases', the resulting frequency figures are for homozygous F/F 34.1%, heterozygous F/V 45.7%, homozygous V/V 68.8% cases ( 2 = 5.44 for trend, P = 0.020). With the Fc␥RIIIb polymorphism, subjects homozygous for the NA1 allele show less bone loss than those bearing the NA1/NA2 or NA1/NA1 genotype, but these differences are not significant. There is no indication of an association between the polymorphism of Fc␥RIIa and periodontitis.
Age and smoking are the most important confounding risk factors in periodontal disease. When the results were re-assessed by a stratified analysis adjusting for smoking, no differences were found in the subgroups which reflected any influence of smoking on the distribution of genotypes. The risk of having bone loss above the median of 37.5% is heightened in subjects bearing one or two V alleles of Fc␥RIIIa as compared to homozygotes of genotype Fc␥RIIIa-158-F/F irrespective of the smoking status. In Table 3 , the crude odds ratio for the homozygous genotype is compared to that after logistic regression procedure adjusting for age and smoking. Homozygous Fc␥RIIIa-F/F subjects were substantially less frequent in periodontitis cases. Stratification revealed no significant differences between non-smokers and ex-smokers, gender was without influence.
Discussion
The high affinity V/V genotype of Fc␥RIIIa is associated with severity and extent of adult periodontal disease in subjects between 40 and 60 years of age. We also found a weak association between the low affinity genotype of Fc␥RIIIb, NA2NA2, and severity and extent of bone loss. The restriction of the age group 40 to 60 years allows comparisons of genetic differences as it excludes subjects with juvenile periodontitis, known to have a different pathogenesis, 9 as well as subjects at an age where periodontitis becomes a common characteristic. 10 No association between Fc␥RIIa genotypes and periodontal disease was found in this study.
The immunoglobulin receptor Fc␥RIIIa (CD16) is expressed on natural killer (NK) cells, macrophages, and sub-populations of T cells. These cells are found in inflamed gingival tissue and their number is increased in patients affected with periodontal disease. 11, 12 In response to IgG binding, cells expressing the Fc␥RIIIa-158VV genotype exhibit increased cell activation as compared to cells carrying the 158-FF genotype. 13 The activation of the receptor mediates the release of cytokines, phagocytosis and cell-mediated cytotoxicity.
14 Especially, macrophages expressing interleukin 1 play an important role in the activation and recrudescence of osteoclastic bone resorption. 15, 16 Thus, it may be assumed that in response to a more effective IgG-binding, as seen in individuals carrying the Fc␥RIIIa-158VV genotype, the osteoclastic activity is enhanced and, therefore, the remaining bone support is diminished as compared to subjects bearing less effective receptors. If increased production of interleukin IL-1 is the initial step and is crucial for the pathogenesis, then the finding of an association between the frequency of the Fc␥RIIIa-158V alleles and the extent of bone loss corresponds to the role of IL-1 polymorphism in periodontal disease. 17 Accordingly, mutations in this IL-1 gene produce a polymorphism with enhanced IL-1 production and individuals bearing such a genotype are at an enhanced risk of developing periodontitis.
The low affinity Fc␥RIIIb-NA2NA2 genotype was found to be slightly over-represented among cases with severe periodontitis, thereby not supporting our above hypothesis. As a matter of fact, the Fc␥ genes are clustered within a distance of 0.5 MB on chromosome 1, making probable linkage disequilibrium between Fc␥RIIIa and IIIb. In Table 4 the haplotype distribution is shown. Thus, the weak association of the low affinity Fc␥RIIIb genotype can be explained by linkage disequilibrium between the Fc␥RIIIa-158F and the IIIb-NA2 alleles. The distribution shows a significant difference between observed and expected combinations, and no individual carrying the combination RIIIa-V/V and IIIb-NA1/NA1 was found. This may be an explanation for the skewed distribution of Fc␥RIIIb genotypes, but should be confirmed in a larger control population.
Polymorphisms of the Fc␥ receptors are possible explanations for the individual susceptibility to infections with Gram-negative bacteria in the subgingival plaque formation. Previous results have shown an increased frequency of the Fc␥RIIa R131 allele in patients with periodontitis 18 and in patients with juvenile periodontitis having an enhanced bacteriostatic effect on A. actinomycetemcomitans. 19 We could not demonstrate any association between the development of periodontitis and the genotype distribution of Fc␥RIIa, which is in line with the study of Colombo et al 20 who were unable to find an association between Fc␥RIIa genotype distribution and the clinical status in refractory periodontal disease.
A significant over-representation of the Fc␥RIIIa-158F alleles was reported in Japanese patients with adult recurrent periodontitis. 21 In that study, there was no difference in allele frequencies between patients and controls; only patients with recurrence of periodontitis exhibited this allelic predominance of Fc␥RIIIa-158F. Kobayashi et al 22 reported a significant over-representation of the Fc␥RIIIb-NA2 allotype in Japanese patients with recurrent disease. The same authors have shown that polymorphonuclear neutrophils isolated from Fc␥RIIIb-NA2 carriers are less efficient in phagocytosis upon interaction with IgG1-and IgG3-opsonized P. gingivalis. 23 These data are in agreement with our findings showing a trend of Fc␥RIIIb-NA2 over-representation in patients with more severe bone loss.
The discrepancies between the different studies may be explained by ethnic differences as well as by the selection of patients. Investigations addressing periodontitis are difficult to compare. For one, most of the diagnostic parameters are subjective, necessitating calibrated investigators. Additionally, arbitrary units are often used. Computer evaluated radiography to determine bone loss is thus one of few objective methods, yet not all studies assess this parameter. A further difficulty in periodontitis case-control studies is the lack of healthy controls. Periodontitis develops over the years and hardly any individual is completely unaffected. Thus, comparisons have to be made between mild and severe disease. With respect to probing depth and attachment loss as parameters to distinguish between healthy controls and periodontitis patients, the results presented here correspond to those of others.
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Materials and methods
Subjects
A total of 154 patients from the outpatient Department of Periodontology, University of Greifswald, Germany, were included in this study. Subjects underwent maintenance therapy for at least 2 years and gave their informed consent. Excluded were subjects having fewer than 12 non-crowned teeth or those taking anti-inflammatory drugs.
Periodontal charting was performed by three independent calibrated examiners, comprising number of teeth, clinical probing depth, clinical attachment loss, bleeding on probing, and bone loss (measured from radiographs, Figure 1 ). Bone loss was expressed as fraction of the total tooth length (A/C), and calculated as percent bone loss (A/C in relation to A/C+B/C). This parameter lacks if the alveolar bone crest could not be identified. Probing depth and attachment loss were assessed at four sites per tooth: mesiobuccal, mid buccal, distobuccal, and mid-lingual or palatinal. Attachment loss was determined by measuring the distance from the cemento-enamel junction to the base of the pocket (PCP11 Probe, Hu-Friedy, USA). The periodontal bone height was determined from the panoramic radiographs (Orthopos, Siemens Bensheim, Germany) by means of an image analysis system (analySIS, Soft Imaging System, Mü nster, Germany). Number of teeth, mean attachment loss, mean probing depth, bleeding on probing, and mean bone loss were taken as measures in the definition of the severity of periodontitis.
Genotyping
The polymorphic sites of the Fc␥RIIa, RIIIa, and RIIIb genes were determined using genomic DNA extracted from venous blood and PCR methodology. The methods for genotyping were essentially as described elsewhere: Fc␥RIIa-131H/R, 24 Fc␥RIIIa-158V/F 25 and Fc␥RIIIb-NA1/NA2, 26 respectively.
Data analysis
Diagnosis of periodontal disease comprises both severity of disease and extent of disease. Severity was defined as the patient's mean of the diagnostic measure (mean probing depth, mean bone loss, mean attachment loss). The extent of periodontitis was defined as the percentage of all sites per subject displaying a given condition, exceeding a predetermined limit. The limit for bone loss was set at loss Ͼ0.2 (ratio A/C in Figure 1 ). For all frequency data the 95% confidence intervals were calculated. Periodontal disease shows a wide variability exhibiting a continuous distribution from minor affection to the most severe sequel including tooth loss. Thus, for separation between groups of severely affected patients and those with mild or moderate periodontal disease, the subjects were distributed into quartiles with respect to the diagnostic outcome criteria, the median was used as cutoff between severely and moderately/mildly affected cases. Relative frequencies of the genotypes were compared using 2 statistics for contingency tables. Crude odds ratios were calculated from the ratios in a 2 × 2 contingency table. Relative risks were computed by logistic regression analysis, with consideration of confounding variables. Statistical differences between genotypes were assessed by using the non-parametric Kruskal-Wallis test.
Tests were analysed using the StatView program (SAS Institute, Cary NC, USA).
